DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein
Clinical trial NCT03368196 · COMPLETED
Trial details
- NCT number
- NCT03368196
- Sponsor
- Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-02
- Primary completion
- 2018-09-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.